Field safety notices: Vascutek
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
11 authority publications by 5 authorities, from 7 Nov 2024 to 13 Nov 2026.
Latest notice: 13 Nov 2026, BfArM, Gelweave Vascular Prosthesis
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Vascutek or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
4 distinct corrective actions.
- Gelweave Vascular Prosthesis
Source: BfArM – Safety instructions in the field · collected 16 Nov 2026
Corrective action: 4 publications by AEMPS, ANSM, IGJ, MHRA, from 16 Mar 2026 to 25 Mar 2026
- Prótesis Thoraflex Hybrid
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- Prothèse de l’aorte thoracique Thoraflex Hybrid
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Vascutek Ltd., FSN2026-001, Thoraflex Hybrid
Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026
- MHRAUnited Kingdomofficial source: Thoraflex Hybrid, MHRA, 2026-03-16Thoraflex HybridModels, lots, UDI: Thoraflex Hybrid Ante-Flo, Thoraflex Hybrid Plexus
Source: MHRA, Field Safety Notices, gov.uk (Open Government Licence v3.0) Contains public sector information licensed under the Open Government Licence v3.0. · collected 16 Nov 2026
Corrective action: 3 publications by AEMPS, ANSM, MHRA, from 15 Dec 2025 to 14 Jan 2026
- - Gelsoft PlusModels, lots, UDI: - Gelweave ; - Thoraflex Hybrid ; Números de artículo fabricados desde abril de 2025 que acaben en E-B
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- ANSMFranceofficial source: Prothèses vasculaires Gelweave, Gelsoft Plus et Thoraflex Hybrid, ANSM, 2025-12-23Prothèses vasculaires Gelweave, Gelsoft Plus et Thoraflex Hybrid
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Gelweave, Gelsoft Plus, Thoraflex HybridModels, lots, UDI: All MDR SYGMA (item code ending “E-B”)
Source: MHRA, Field Safety Notices, gov.uk (Open Government Licence v3.0) Contains public sector information licensed under the Open Government Licence v3.0. · collected 17 Nov 2026
Corrective action: 3 publications by AEMPS, ANSM, IGJ, from 7 Nov 2024 to 5 Dec 2024
- Prótesis Thoraflex Hybrid
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- IGJNetherlandsofficial source: VASCUTEK LIMITED, FSN 2024_001; FSN 2024_01, Thoraflex Hybrid, IGJ, 2024-11-25VASCUTEK LIMITED, FSN 2024_001; FSN 2024_01, Thoraflex Hybrid
Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026
- Prothèse vasculaire Thoraflex Hybrid
Source : ANSM, informations de sécurité · collected 16 Nov 2026